Difference between revisions of "Alzheimer Europe"
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
The Guardian reports: | The Guardian reports: | ||
| − | :A member of the European Patients Forum and an umbrella body for national Alzheimer's associations. Over a third of Alzheimer Europe's income (37%) came from the pharmaceutical industry in 2005. The biggest payments were from Lundbeck (€51,683 - £35,347), Janssen-Cilag (€40,000) and Pfizer (€39,230). The Alzheimer's Society in the UK accepts far less from drug companies - donations amounted to less than 1% of income in the financial year 2005-06.<ref>Sarah Boseley, health editor [http://www.guardian.co.uk/medicine/story/0,,2084179,00.html Drug firms and patient groups join in fight to overturn advertising ban] Monday May 21, 2007 The Guardian </ref> | + | :A member of the [[European Patients Forum]] and an umbrella body for national Alzheimer's associations. Over a third of Alzheimer Europe's income (37%) came from the pharmaceutical industry in 2005. The biggest payments were from [[Lundbeck]] (€51,683 - £35,347), [[Janssen-Cilag]] (€40,000) and [[Pfizer]] (€39,230). The [[Alzheimer's Society]] in the UK accepts far less from drug companies - donations amounted to less than 1% of income in the financial year 2005-06.<ref>Sarah Boseley, health editor [http://www.guardian.co.uk/medicine/story/0,,2084179,00.html Drug firms and patient groups join in fight to overturn advertising ban] Monday May 21, 2007 The Guardian </ref> |
==Notes== | ==Notes== | ||
<references/> | <references/> | ||
| + | [[Category:Patient Groups]] | ||
Latest revision as of 08:00, 22 October 2007
The Guardian reports:
- A member of the European Patients Forum and an umbrella body for national Alzheimer's associations. Over a third of Alzheimer Europe's income (37%) came from the pharmaceutical industry in 2005. The biggest payments were from Lundbeck (€51,683 - £35,347), Janssen-Cilag (€40,000) and Pfizer (€39,230). The Alzheimer's Society in the UK accepts far less from drug companies - donations amounted to less than 1% of income in the financial year 2005-06.[1]
Notes
- ↑ Sarah Boseley, health editor Drug firms and patient groups join in fight to overturn advertising ban Monday May 21, 2007 The Guardian
